Emphysema Symptoms


Emphysema Symptoms

Emphysema symptoms are not always immediately apparent. In fact, some people can have the condition for several years before they experience any noticeable discomfort. Typically, the first sign to appear is shortness of breath, which is usually mild at first and gradually intensifies over time. Most people seek treatment when their breathing difficulties cause them to avoid certain activities and interfere with their quality of life.

In addition to shortness of breath and a general feeling that they can’t get enough air, many people with emphysema experience additional symptoms such as:

  • Persistent coughing
  • Wheezing
  • Excessive mucus production
  • Chest pain or tightness
  • General fatigue
  • Loss of appetite
  • Depression

Traditionally, several approaches have been used to help relieve the symptoms of emphysema. Some patients benefit from the use of bronchodilators, inhaled steroids, antibiotics, pulmonary rehabilitation, nutrition therapy and/or supplemental oxygen. However, while these techniques can help with symptom control, they cannot address the underlying cause of emphysema within the lungs. To achieve this, lung volume reduction surgery or a lung transplant may be recommended, but usually only in very severe cases.

For patients who are looking for an alternative treatment for emphysema and its symptoms, the Lung Institute offers a promising option: stem cell therapy. Specifically, we use autologous stem cells derived from a patient’s own body to help promote healing within the lungs and potentially slow the progression of lung damage. The latter aspect is especially important because emphysema has no cure — it is a chronic condition that worsens over time.

If traditional forms of treatment for emphysema symptoms have not provided you with the relief you need, you may benefit from the Lung Institute’s groundbreaking alternative. To learn more about stem cell therapy for chronic lung conditions, contact us at (800) 729-3065. Our innovative treatments are performed on an outpatient basis, and comprehensive follow-up care is provided by our caring medical team.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.